Xintian Pharma
0028737.682.54% ( +0.19 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Xintian Pharma(002873) the Revenue is 178.61 M (-7.53%);the EBIT is 10.77 M (+14.96%);the EPS is 0.0143 (-16.86%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.18B7.53%
----
----
EBIT
0.01B14.96%
----
----
EPS
0.014316.86%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf